(Q36555238)

14 August 2017

1 reference

title

Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors (English)

1 reference

14 August 2017

1 reference

1 reference

Marianne C Verhaar

2

0 references

author name string

Kim E Jie

1

1 reference

14 August 2017

Maarten-Jan M Cramer

3

1 reference

14 August 2017

Karien van der Putten

4

1 reference

14 August 2017

Carlo A J M Gaillard

5

1 reference

14 August 2017

Pieter A Doevendans

6

1 reference

14 August 2017

Hein A Koomans

7

1 reference

14 August 2017

Jaap A Joles

8

1 reference

14 August 2017

Branko Braam

9

1 reference

14 August 2017

language of work or name

1 reference

1 August 2006

1 reference

American Journal of Physiology - Renal Physiology

14 August 2017

published in

1 reference

14 August 2017

volume

291

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

F932-44

1 reference

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin modulates angiotensin II- or noradrenaline-induced Ca(2+) mobilization in cultured rat vascular smooth-muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin upregulates angiotensin receptors in cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The anemia of primary autonomic failure and its reversal with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The severe cardiorenal syndrome: 'Guyton revisited'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Angiogenesis and plasticity: role of erythropoietin in vascular systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Effects of an essential oil from the bark of Croton cajucara Benth. on experimental gastric ulcer models in rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Nuclear factor kappa B activation by NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Sympathetic overactivity in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Serum iron level, coronary artery disease, and all-cause mortality in older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Effect of erythropoietin on bcl-2 gene expression in rat cardiac myocytes after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The erythropoietin receptor and its expression in tumor cells and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Anemia as a risk factor and therapeutic target in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Comparative beta-adrenoceptor blocking effects of propranolol, bisoprolol, atenolol, acebutolol and diacetolol on the human isolated bronchus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Distinct components of Janus kinase/signal transducer and activator of transcription signaling pathway mediate the regulation of systemic and tissue localized renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

21 January 2018

Anaemia and the heart

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin and VEGF exhibit equal angiogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Differential roles of SOCS family members in EpoR signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Molecular biology of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Effects of antioxidant vitamins on renal and hepatic erythropoietin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin administration in vivo increases vascular nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Anemia: an early complication of chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Sympathetic hyperactivity in chronic renal failure: a wake-up call

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Suppressors of cytokine signalling: SOCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

New avenues of exploration for erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

SOCS3 is essential in the regulation of fetal liver erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin receptor-operated Ca2+ channels: activation by phospholipase C-gamma 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Epoetin treatment improves red blood cell and plasma antioxidant capacity in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

[Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Haemodynamic effect of recombinant human erythropoietin on hypotensive haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

A novel protective effect of erythropoietin in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Biological significance of MAPK, AKT and JAK-STAT protein activation by various erythropoietic factors in normal human early erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Role of NF-kappa B in regulation of apoptosis of erythroid progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Neuropeptide Y is an inducible gene in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Intravenous iron therapy: well-tolerated, yet not harmless

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

AP-1 in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The cardiovascular effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Mechanism of erythropoietin-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin protects against ischaemic acute renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin depresses nitric oxide synthase expression by human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Human, rat, and mouse kidney cells express functional erythropoietin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Extracellular superoxide dismutase functions as a major repressor of hypoxia-induced erythropoietin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Neuropeptide Y. A novel sympathetic stress hormone and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric Oxide Synthesis in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00200.2006

10.1152/AJPRENAL.00200.2006

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference